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The role of terminal deoxynucleotidyl transferase (TdT) in the insertion of N regions into the junctional sites
of immunoglobulin genes was investigated. Pre-B-cell lines capable of continuous rearrangement of immuno-
globulin light-chain genes and differing only in the presence or apparent absence of TdT were derived by
infecting cells with a TdT retroviral expression vector or a control vector. The cell lines were then superinfected
with a retrovirus-based artificial immunoglobulin gene rearrangement substrate. The substrate was allowed to
rearrange in the cell lines and the rearranged proviruses were rescued from the cell lines. Nucleotide sequence
analysis of the V-J junctions of the proviral rearranged genes showed a fivefold greater frequency of N-region
insertion in proviruses rescued from the TdT+ cell lines than in those rescued from the TdT- cell lines, so that
at least 50% of the rearrangements that occurred in the presence of TdT had N regions. It is thus evident that
TdT can stimulate N-region insertion, and the enzyme is presumably directly responsible for adding nucleotides
at V-J and other immunoglobulin and T-cell receptor gene junctions.
Terminal deoxynucleotidyl transferase (TdT) is a unique
DNA polymerase that without template direction catalyzes
the addition of deoxyribonucleotides onto the 3'-hydroxyl
ends of DNA primers (5, 15). It is present in the immature
fraction of thymocytes, in a small fraction of bone marrow
cells, in transformed pre-B- and pre-T-cell lines, and in
leukemic cells (8, 10, 18, 27, 35). The enzyme is composed of
a single polypeptide chain of molecular weight 58,000 (6, 29,
36). cDNA clones have been isolated representing mouse
(20), human (31), and bovine (17) TdT.
Initially, it was thought that TdT might be responsible for
the generalized somatic mutation seen throughout the vari-
able regions of immunoglobulin genes (2). Later, it became
evident that this somatic mutation process takes place in the
later stages of B-lymphoid development (13), when TdT is no
longer present (18), and somatic mutation probably does not
occur at all in T-lymphoid cells (9). Another suggestion for
the function of TdT is that it might be responsible for
insertion of small numbers of nucleotides of largely random
sequence at the DNA joints formed during the construction
of immunoglobulin genes from germ line gene fragments.
The sequences of an odd rearrangement in a heavy-chain
gene first suggested this notion (1), and further studies of
joints formed in cells containing or lacking TdT have sub-
stantiated it (4, 11, 39). Sequences not evident in surround-
ing germ line DNA have been observed at V-D and D-J
junctions of both immunoglobulin heavy chains (19) and
T-cell receptor genes (3) but not at the V-J junctions of
immunoglobulin light-chain genes (34). An explicit proposal
is that these nucleotides or nucleotide regions (N regions)
result from the polymerization of random nucleotides by
TdT onto free 3' ends of DNA exposed during gene rear-
rangement (1).
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To test this idea of TdT function directly we have chosen
to insert a functional TdT gene into a cell line that rearranges
K light-chain genes but ordinarily lacks TdT. Such a cell line
is the Abelson murine leukemia virus-transformed line PD31
(23). We introduced an expressed, exogenous TdT gene
through a retroviral vector and then superinfected the cells
with a virus containing K immunoglobulin gene segments
able to rearrange (21, 22). IfTdT was capable of synthesizing
N-regions, we expected to find that immunoglobulin genes
which had rearranged in the presence ofTdT would show an
increased frequency of N regions as compared with those
that had rearranged in cells containing little or no TdT. This
expectation was fulfilled.
MATERIALS AND METHODS
Construction of vectors. The TdT retroviral vectors were
constructed by digestion of pM-TdT or pHM-TdT (see
below) with BamHI and EcoRI, ligation to BamHI linkers,
and ligation to BamHI-cleaved pDOL-. To construct the
DGR retroviral vector, a cloned BALB/c JK1 gene segment
(25), was cleaved with HindIII and Hinfl and reacted with
the large subunit ofDNA polymerase I to blunt the ends and
ligated to NruI-cleaved pBR322. The resulting plasmid was
cleaved with SalI and ligated to the SalI-linkered JK1 restric-
tion fragment. This plasmid was cleaved with SphI and
BamHI and ligated to BamHI-SphI-cleaved VK21-C DNA
(isolated from pVJG [21]). The resulting plasmid was cleaved
with SphI and ligated to the BamHI-BglII-cleaved, SphI-
linked restriction fragment of pVJG containing the gpt gene
and the 3' splice site of murine leukemia virus. A restriction
fragment containing VK21-C, two copies of JK1, and the gpt
gene was excized by cleaving with NheI-PvuII, ligated to
BglII linkers, and ligated to BamHI-cleaved pDOL.
Cell culture. To establish virus producer cell lines, 4-2
cells (24) were transfected with 10 ,ug of plasmid by the
protocol of Graham and Van der Eb (14) as modified by
Parker and Stark (30). Virus was harvested 18 h after the
glycerol treatment, filtered through a 0.45-,um filter, and
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used to infect *-2 cells that had been grown for 18 h in the
presence of tunicamycin (Calbiochem-Behring, La Jolla,
Calif.). The tunicamycin-treated +-2 cells were incubated
with virus for 2 h in the presence of 8 jig of polybrene per ml.
The virus was removed, and the cells were grown for 2 days
in nonselective medium, at which point they were placed
into medium containing 1 mg of G418 (GIBCO Laboratories,
Grand Island, N.Y.) per ml. Single colonies were picked 8 to
10 days later and analyzed by filter hybridization. The titer of
virus produced by the ip-2 producer lines was determined by
adding supernatant from each of the 4i-2 clones to 3T3 cells,
followed by selection of the 3T3 cells in 1 mg of G418 per ml
and counting the number of surviving cell clones. Lympho-
cytes were infected by culturing 105 cells for 2 days on a
monolayer of ip-2 producer cells (titer, =2 x 104 CFU/ml).
Lymphocytes were removed from the 4i-2 cells by gentle
aspiration and cultured in G418 (2 mg/ml) or mycophenolic
acid (0.5 ,ug/ml).
Rescue of proviruses. High-molecular-weight DNA (40 Rg)
was cleaved to completion with XbaI. The DNA was elec-
trophoresed on 0.8%, agarose and the region of the gel from
7 kilobases (kb) to 8 kb was excised. The DNA was purified
by the glass powder method (38) and dissolved in 20 ,ul of TE
(10 mM Tris [pH 8.0], 1 mM EDTA). A sample of the DNA
(5 ,ul) was reacted with T4 DNA ligase in a total volume of
200 p.1 at 25°C for 2 h. The DNA was extracted with
water-saturated phenol and precipitated by the addition of 1
p.g of yeast tRNA, 500 p.1 of ethanol, and 20 ,u1 of 3 M sodium
acetate (pH 6.2). The DNA was incubated on dry ice for 20
min and centrifuged in a microfuge for 10 min. The pellet was
washed in ethanol, dried, and dissolved in 10 ,ul of TE. The
DNA was used to transform 100 p.1 of competent Escherichia
coli MC1061 (transformation efficiency, 5 x 108 colonies per
p.g of pUC13). The transformed bacteria were plated on
Luria broth agar containing 50 p.g of kanamycin per ml.
Nucleic acid hybridization. High-molecular-weight DNA
(10 p.g) was cleaved with restriction enzyme, fractionated by
electrophoresis through 1.0% agarose, transferred to nitro-
cellulose filters and hybridized as described previously (37).
Probes were labeled with [a-32p]dCTP by the hexamer
labeling procedure (12).
Enzyme assays. TdT assays were performed as previously
described (28). Briefly, cells were lysed by the addition of
lysis buffer containing 0.1% Triton X-100-3 M KCI. Lysates
were applied to 0.5-ml phosphocellulose columns. The col-
umns were washed with buffer containing 0.3 M KCI-10 mM
Tris (pH 8.0)-i mM EDTA and eluted with the same buffer
containing 0.5 M KCI. The column fractions were assayed
for TdT activity in a buffer containing 50 mM Tris (pH 8.0)-i
mM dithiothreitol-5 p.g of oligo(dA)12 18 per mI-1 p.Ci of[a-32P]dGTP-2 nM dGTP-0.2 mM MnCl2, and incorporation
was measured by scintillation counting of trichloroacetic
acid-precipitable label.
RESULTS
TdT retroviral expression vector. A TdT gene functional in
bacteria was constructed by fusing the 5' end of a mouse
TdT cDNA to a human cDNA clone lacking 5' sequence;
this we call HM-TdT. The protein encoded by HM-TdT
contained 13 amino acid differences from the authentic
human enzyme (32). We had initially planned to use a
full-length mouse cDNA isolated by using a partial cDNA
(20). This clone, however (referred to henceforth as M-TdT),
yielded only inactive protein when tested in bacteria and has
been used as a negative control. The nucleotide sequence of
M-TdT was identical to that of a previously reported murine
TdT cDNA with the exception of a small number of point
mutations (17). The cDNAs for the inactive M-TdT and
active HM-TdT were trimmed of 5' and 3' untranslated
regions and inserted into the pDOL plasmid that produces
the DOL retrovirus (17a), yielding pDOL-M-TdT and
pDOL-HM-TdT (Fig. 1A). In addition to TdT, these retro-
viruses express the neo gene, encoding G418 resistance,
driven by the simian virus 40 promoter (Fig. 1A).
Cell lines that stably produced the DOL--TdT viruses
were established and those producing the highest titers of
G418' virus were used in further experiments. The structure
of the proviruses in the virus producer cell lines and of 3T3
cells infected by the viruses produced by the cell lines was
studied by DNA blotting analysis. This analysis showed that
each line contained a single provirus whose size was identi-
cal to that of the intact DOL--TdT virus and that the viruses
produced represented intact copies of the retroviral expres-
sion vectors (data not shown).
Expression of TdT enzymatic activity in TdT retrovial
infected cells. The ability of the retroviruses to direct the
synthesis of enzymatically active TdT in mammalian cells
was initially tested by assaying for the presence of TdT in
virus-infected 3T3 cell clones. Lysates prepared from
DOL--M-TdT virus-infected cell lines showed insignificant
levels of TdT activity. Each of the four DOL--HM-TdT
virus-infected cell clones tested showed levels of TdT activ-
ity comparable to that found in the RL 11 cell line (Table 1).
RLc11 has been shown previously to synthesize a level of
TdT similar to that of a normal, TdT+ thymocyte (10). There
was no morphological difference between the TdT+ and
TdT- 3T3 cells, nor did the cell lines show a clear difference
in their cell division rates. TdT expression at physiological
levels is therefore not toxic to 3T3 cells.
The Abelson murine leukemia virus-transformed pre-B-
cell line PD31 was then infected with the DOL--M-TdT and
DOL--HM-TdT viruses. The cells were separated into 12
groups and grown in the presence of G418 to select for cells
that had stably integrated and expressed the viral genome.
Lysates of two DOL--M-TdT-infected PD31 cell lines
showed no significant activity, whereas all three of the
DOL--HM-TdT-infected PD31 cell lines tested showed TdT
activity levels comparable to that of RLS11. Thus, DOL--
HM-TdT can direct synthesis of physiological TdT levels
stably in PD31 cells.
Introduction of an artificial gene rearrangement substrate
into TdT-positive and -negative PD31 cells. An artificial gene
rearrangement substrate, DGR, which could be efficiently
introduced into lymphocytes was constructed in the DOL
retroviral vector (17a) in a manner similar to that previously
described (21) (Fig. 1B). On the 3' side of the 5' long terminal
repeat was placed the VK21-C gene with its flanking
heptamer-nonamer sequences followed by the bacterial gua-
nine-xanthine phosphoribosyltransferase gene (gpt) gene.
Both genes were placed in the opposite transcriptional
orientation from the viral long terminal repeat such that the
full-length viral transcript could not encode gpt. On the 3'
side of the gpt gene were placed two identical copies of the
JK1 gene (the duplication of the JK1 gene segment relates to
other uses of the DGR vector). Immunoglobulin recombi-
nase-mediated inversion of the DNA containing the VK21-C
and gpt genes can join the VK-21-C gene to either of the two
JK1S, placing the gpt gene in the appropriate orientation and
position to allow the proviral transcript to encode gpt
protein, which can be measured as resistance to mycophe-
nolic acid (Fig. 1C). Selection in mycophenolic acid of a
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FIG. 1. Structure of the DOL--TdT and DGR retroviral vectors. (A) DOL--TdT retroviral expression vector containing murine leukemia
virus long terminal repeats and a packaging sequence to allow for transmission of the vector as a retrovirus. The proviral form of the vector
was expected to direct transcription of two RNAs (arrows): one full-length transcript originating at the 5' long terminal repeat promoter and
serving as a template for synthesis ofTdT and a second transcript originating in the simian virus 40 promoter and encoding the Tn5 neomycin
phosphotransferase (neo) gene allowing selection of murine cells and bacteria harboring the vector. The pBR322 origin allowed replication
of the plasmid form of the vector in bacteria; the polyomavirus early region included in the plasmid form served to increase the titer of
retrovirus during transient transfection of the helper virus-free packaging cell line, 4-2. (B) DGR-directed transcripts (arrows) and conserved
heptamer-nonamer sequences (4 ). (C) Structure of the DGR vector immunoglobulin genes after inversional gene rearrangement. The
direction of transcription is indicated by arrows. The sizes of BamHI-HindIIl fragments expected are indicated. Abbreviations: 5'ss, 5' splice
site; 3'ss, 3' splice site; LTR, long terminal repeat; B, BamHI; H, HindIll; Sp, Sphl; X XbaI.
population of cells infected with DGR should therefore only
permit growth of cells harboring a rearranged DGR provirus
while eliminating cells harboring no provirus or an unrear-
ranged provirus. DGR virus was produced by transfecting
the *-2 packaging cell line with pDGR yielding the producer
cell line *-iGR (see Materials and Methods).
PD31 cells were infected with the DGR virus by cocultiva-
tion with qf-iGR. The qf-iGR cell line contained a single copy
of an intact DGR genome and did not rearrange the DGR
virus with efficiencies detectable in these experiments (data
not shown). After 3 days of cocultivation, the PD31 cells
were removed from the fibroblast monolayer by gentle
aspiration and cultured in the presence of G418 to select for
infected cells followed by further selection for gpt expres-
sion in mycophenolic acid-containing medium. A second
group of PD31 cells was infected with DOL--HM-TdT virus
and selected in G418; the surviving cells were expanded for
2 weeks, at which time they were infected with DGR virus.
Infection of these cells with the DGR virus could not be
selected in G418 because the presence of the DOL--HM-
TdT provirus rendered both the DGR-infected and unin-
fected PD31 cells resistant to G418. Instead, the cells were
separated into 24 populations to insure independence of the
rearrangement events and selected directly in mycophenolic
acid-containing medium, according to the strategy of Lewis
et al. (21). This treatment selected for cells containing a DGR
provirus and which had, in addition, rearranged the DGR
provirus allowing for expression of mycophenolic acid
resistance. After 2 weeks of selection the vast majority of
cells had died and been replaced by resistant cells. Approx-
imately 80% of the wells showed growth.
The configuration of the VK21-C gene and the JK genes of
DGR virus-infected PD31 cells was assessed by cleavage of
DNA with BamHI plus HindIll. The cleaved DNA was size
I-
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TABLE 1. Expression of TdT activity in fibroblasts and
lymphocytes infected with TdT retroviral expression vectors
Vector0 Cell line Ub
DOL--M-TdT 3T3-la 0.10
DOL--M-TdT 3T3-2a 0.12
DOL--HM-TdT 3T3-1 0.52
DOL--HM-TdT 3T3-2 0.42
DOL--HM-TdT 3T3-3 0.26
DOL--HM-TdT 3T3-5 0.21
DOL--M-TdT PD31-la 0.06
DOL--M-TdT PD31-2a 0.11
DOL--HM-TdT PD31-4 1.30
DOL--HM-TdT PD31-6 0.52
DOL--HM-TdT PD31-7 0.52
RLd-11 0.45
a Stably infected cell lines were establishd by infection with virus produced
by *-2 producer cell lines, which produced virus at titer of 2 x 104 CFU/ml
and contained a single, intact proviral copy.
b Assays were performed as described in Materials and Methods. Back-
ground was about 0.1 U. One unit of enzyme activity is equal to 1 nmol of
dGMP incorporated per h.
fractionated by agarose gel electrophoresis, transferred to a
nitrocellulose filter, and hybridized to a radioactive probe
derived from pBR322 sequences lying 3' to JK1-b in DGR
(Fig. 1B, probe 1). BamHI cleaved the unrearranged
provirus at two closely spaced sites near the 3' end of the
VK21-C gene, whereas HindIII cleaved at a single site in the
neo gene, releasing a 3.8-kb BamHI-HindIII fragment (Fig.
1B). Rearrangement of the DGR VK21-C gene to JK1-a or to
JK1-b released 1.9- or 1.5-kb BamHI-HindIII fragments,
respectively. DGR proviruses of several of the infected cell
lines showed the expected 1.9-kb (Fig. 2, lanes 3, 10, and 12)
and 1.5-kb (Fig. 2, lanes 4 through 8) fragments. None of the
cell lines showed the 3.8-kb fragment indicative of the
unrearranged DGR provirus. These results showed that the
DGR provirus had rearranged in the PD31 cells such that
VK21-C had joined to one or the other of the two JK1 genes.
Four fragments were observed whose sizes were close to
but different from those expected. Two of the fragments
could be explained by loss of the BamHI site closest to the
V-J junction due to the deletion of nucleotides in this region
which accompanies gene rearrangement. In this case,
BamHI would cleave only at the BamHI site located 100
base pairs further upstream in the VK21-C gene, explaining
the observation of fragments of 2.0 kb (data not shown) and
1.6 kb (Fig. 2, lane 12) instead of 1.9 and 1.5 kb. A third
fragment of 1.8 kb was seen in several of the cell lines (Fig.
2, lanes 1, 4 through 9, and 11). DNA sequencing showed
that this resulted from an irrelevant deletion of approxi-
mately 100 base pairs due to a splicing artifact. This splice
presumably occurred before packaging of the DGR retroviral
DNA in the 4-iGR producer cell line. A fourth fragment of
1.4 kb probably arose by a splice analogous to that of the
1.8-kb fragment (data not shown).
The presence of more than one of the rearranged frag-
ments in some of the cell lines (Fig. 2, lanes 4 through 8 and
12) was attributed to the presence of two or more cell clones
in some of the cell lines. This result was expected, because
mycophenolic acid selection of the DGR-infected PD31 cells
showed growth in a large fraction of the wells. Each of the
cell lines was monoclonal or biclonal, with the exception of
cell line 6.2, which was triclonal (data not shown). Each of
the DGR proviruses was the result of an independent inte-
gration of the retrovirus as shown by flanking restriction
enzyme cleavage sites.
Rescue of the DGR provirus from the PD31 infectants. To
determine the sequence of a large number of the VK21-C-JK1
junctions in the rearranged DGR proviruses, we developed a
method for rapidly isolating proviral DNA from the infected
PD31 cells lines. Extensive attempts to rescue the proviruses
of the DGR-infected PD31 cells by COS cell fusion (7)
resulted in an unacceptably low efficiency of rescue (data not
shown). Instead, we attempted to rescue the proviral DNA
directly from high-molecular-weight DNA isolated from the
DGR-infected PD31 cell lines. This procedure took advan-
tage of the ability of the DOL vector to replicate as a plasmid
and to express the neo gene in E. coli, thereby allowing
selection of plasmid-containing bacteria with kanamycin.
High-molecular-weight DNA from each of the DGR-infected
PD31 cell lines was digested to completion with XbaI to
release the proviral DNA. To enrich for proviral sequences,
the DNA was size fractionated by agarose gel electrophore-
sis, and restriction fragments in the range of 7 to 8 kb were
isolated. This size range should include proviruses with each
of the observed rearrangements. The isolated DNA was
circularized and used to transform E. coli.
Transformation of E. coli without DNA or with 3T3 DNA
processed as described above resulted in no colonies. Trans-
formation with DNA from the DGR-infected PD31 cell lines
resulted in an average of 20 bacterial colonies per cell line.
Plasmid DNA was isolated from six colonies of each trans-
formation. The DNA was cleaved with BamHI and HindIlI
and size fractionated by agarose gel electrophoresis. The
sizes of the BamHI-HindIII fragments containing the Vk21-
C-JK1 junction were compared with the sizes of the frag-
ments observed with the same restriction digest in the
genomic DNA of the DGR-infected PD31 cell lines. In each
case the BamHI-HindIII fragment observed in the genomic
DNA was of the same size as that of the rescued plasmid
(data not shown). In cell lines that showed two or three
different-sized BamHI-HindIII fragments, the rescued plas-
mid DNAs showed plasmids with fragments of the corre-
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FIG. 2. Rearrangements ofDGR provirus in infected PD31 cells.
High-molecular-weight DNA (10 ,ug) was digested with BamHI-
HindIII, electrophoresed through 1.2% agarose, transferred to ni-
trocellulose, and hybridized to radioactive probe 1 DNA. Lanes:
Ml, pBR322 markers; M2, markers derived from rescued plasmids;
1 through 12, cell lines 6.16, 6.1, 6.5, 6.9, 6.10, 6.11, 6.14, 6.15, 6.16,
6.18, 6.12, and 6.4, respectively.
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TABLE 2. Sequences around V-J junction of rearranged DGR rescued plasmids
GGATCCTCCa GTGGACGTTCGGTGGAGGCACCAAGb Cell line' Fragment sized TdT virus TdT level'
AC ------------------------- 10.1 1.5 ND
-------- ----------------------- 10.2 1.5 NT
------ ----------------------- 10.3 1.5 ND
------
----------------------- 10.4 1.9 ND
-------------------- 10.5 1.5 NT
-------- ----------------------- 10.6 1.9 NT
-------- ----------------------- 10.7 1.9 NT
-----
------ 10.8 2.0 NT
----
------------- 6.2 1.6 DOL--HM-TdT NT
------------- 6.2 2.0 DOL--HM-TdT NT
GA --------------------- 6.2 1.9 DOL--HM-TdT NT
------ ----------------------- 6.4 1.4 DOL--HM-TdT 21
--------
---------------------- 6.5 1.8 DOL--HM-TdT ND
-------- ----------------------- 6.5 1.9 DOL--HM-TdT ND
------- G ------------------------- 6.6 1.8 DOL--HM-TdT 91
------ ------------------------
- 6.7 1.5 DOL--HM-TdT ND
--------- ------------------------- 6.8 1.5 DOL--HM-TdT 17
------- ------------------------- 6.11 2.0 DOL--HM-TdT NT
---
--------------------- 6.9 1.5 DOL--HM-TdT 30
TCCCA - - -- - - - - -- - - - - -- - - - - -- - 6.9 1.9 DOL--HM-TdT 30
------- ---------------------- 6.10 1.5 DOL--HM-TdT 16
----- - CT ----------------- 6.10 1.8 DOL--HM-TdT 16
--------- GA --------------------- 6.15 1.5 DOL--HM-TdT 14
------ CT ------------------------ 6.15 1.8 DOL--HM-TdT 14
-------- ------------------------ 6.16 1.5 DOL--HM-TdT 10
A ---------------------- 6.18 1.5 DOL--HM-TdT 100
a.b Sequences of the 3' end of V,,21-C (a) and the 5' end of J, 1 (b) up to the conserved heptamer-nonamer sequences. Dashes indicate germ line sequence. Non-
germ line nucleotides are shown in boldface type.
I PD31 cell lines containing independent insertions of the DGR provirus.
d HindIII-BamHI fragment size in kilobases of rescued plasmid.
' TdT was assayed in control cell lines by RNA blotting with a radioactive M-TdT probe. DOL--HM-TdT virus-infected cell lines were assayed for TdT activity
as described in Materials and Methods. Units are arbitrary and set to 100 for the most active cell line. This cell line had activity equivalent to that of RLd 11. ND,
Not detectable; NT, not tested.
sponding sizes. Thus, it was possible by this method to
rapidly and efficiently rescue single-copy or low-copy-
number plasmids directly from the genomic DNA of cells.
The rescued plasmids accurately reflected the proviruses
contained in the DGR virus-infected PD31 cell lines.
Sequences of the VK21-C-JK1 junctions of the rescued
plasmids. The nucleotide sequence of VK21-C-JK1 junctions
of the rescued plasmids was determined by labeling the
BamHI site of the plasmid DNA and subjecting the DNA to
the sequencing reactions of Maxam and Gilbert (26). Ap-
proximately 100 base pairs of sequence was determined for
each fragment. Of the sequences derived from the control
cell lines, all except for one of the eight V-J junctions
contained direct joins of V,,21-C to JKJ-a or to JKJ-b with, as
expected, loss of a few nucleotides (22) (Table 2). Of the
plasmids derived from DOL--HM-TdT virus-infected PD31
cells, 39% (7 of 18) showed non-germ line nucleotides at the
VK21-C-JK1 junction (Table 2). All of the N regions consisted
of 1 or 2 base pairs, except for one 5-base-pair N region. Of
the nucleotides further 3' of the V-J junction, all sequenced
nucleotides corresponded to the sequence of JK1, indicating
that the non-germ line-encoded nucleotides were not simply
the result of a high mutation rate of nucleotides in DGR.
Because each DGR virus-infected PD31 cell clone con-
tained an independent integration of the DOL--HM-TdT
virus, it was possible that the cell lines expressed different
levels of TdT. In addition it was desirable to test the TdT
level in the control cell line that showed an N region to test
for the presence of low-level TdT expression. The results of
TdT assays of lysates prepared from several of the DOL--
HM-TdT-infected cell lines showed that three of the cell
lines had TdT levels that were not detectable over back-
ground (Table 2). These cell lines showed germ line V-J
junctions. One of the cell lines contained two different DGR
rearrangements. Of the rearrangements which showed N-
region addition, all (five of five) of the corresponding cell
lines showed significant TdT levels. The TdT in the cell lines
varied considerably from physiological to undetectable lev-
els, probably due to differences in the integration site of the
DOL-HM-TdT provirus in each cell line. To determine as
sensitively as possible the TdT levels in the control cell line,
10.1, whose rescued plasmid showed an N region, RNA
hybridization analysis was performed. Hybridization of a
radioactive TdT probe to size-fractionated RNA from this
cell line showed no detectable TdT RNA, whereas RL 11
showed a strong band (data not shown). The 10.1 cell line
therefore contained at most a very low level of TdT.
DISCUSSION
We have investigated the role of TdT in the insertion ofN
regions into the junctional regions of immunoglobulin genes.
Previous studies on the role of TdT in the insertion of N
regions relied on cell lines which differed in TdT level but
which also could have differed in the expression of gene
products which might be coordinately regulated with the
TdT gene (11, 39). In the present study we sought to
overcome this difficulty by establishing cell lines which
differed from one another only by the expression of TdT.
This was accomplished by the introduction of a TdT retro-
viral expression vector into a TdT- cell line. The resulting
fibroblast and pre-B-cell lines showed physiological TdT
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activity levels. TdT expression in the infected cell lines was
encoded by the introduced TdT gene and not the endogenous
TdT gene, because introduction of a control retroviral
expression vector containing a mutant TdT cDNA did not
induce TdT expression. It was of interest that the presence
of TdT had no obvious toxic effect on 3T3 cells, although it
could lead to subtle effects such as an increased mutation
rate.
Comparison of immunoglobulin V and J sequences rear-
ranged in the presence or absence of TdT showed a striking
difference. About 10% of the control segments contained N
regions, whereas 50% of the segments rearranged in the
presence of detectable TdT contained N regions. The control
value (one of eight) is consistent with a previous observation
of one of nine rearrangements containing N regions in the
absence of detectable TdT with a gene rearrangement sub-
strate similar to that used here (22). The cause of these
apparently TdT-independent N regions is not clear. They
could be caused by a very low level of TdT, undetectable
even by mRNA analysis; by transient expression of TdT in a
rare cell, which would not later be detected; or by a truly
TdT-independent process. Short runs of sequence have been
found in nonimmunoglobulin DNA joints (33), and the mech-
anism behind our observation could be similar.
Although 7 of 18 genes rearranged in HM-TdT virus-
infected cells contained N regions, at least four of those
lacking N regions were found to have occurred in cells that
lacked TdT expression. These cells contained the integrated
HM-TdT provirus but, presumably due to position effects or
promoter competition, did not express a detectable amount
of enzyme. Thus, at least 50% of the rearrangements made in
the presence of TdT had N regions.
Our determinations of N-region lengths are minimum
estimates because we are assuming that every germ line-
encoded nucleotide. found represents a true germ line nucle-
otide. Some fraction certainly represents N-region nucleo-
tides that fortuitously agreed with the germ line sequence.
This problem should affect the control and experimental data
similarily.
We conclude that TdT can increase the frequency of N
region insertion by at least fivefold. Actually, the control
level may represent a process quite different from that
catalyzed by TdT, but we presently have no way to distin-
guish the two possibilities. Furthermore, the frequency of
N-region insertion appears low compared with that in au-
thentic heavy-chain joints. This may reflect the use of an
artificial substrate or the use of K-gene segments, which
ordinarily probably do not rearrange in the presence of TdT.
We chose to investigate K-gene rearrangements purposely to
illustrate the efficiency of TdT, but we may have given the
enzyme a particularly difficult task. This may also explain
the relatively short length of most of the N regions we
observed.
The results presented here are likely to apply equally well
to T-cell receptor N regions; both gene families use the same
recombinase (39) and the same conserved heptamer-nona-
mer sequence (9) and rearrange at a stage of lymphocyte
maturation during which TdT is present (18). N-region
diversity may take on added importance in the generation of
the T-cell receptor repertoire in light of the apparent lack of
somatic hypermutation of T-cell receptor genes (9), in con-
trast to immunoglobulin genes where such mutations play a
large role in diversification (16). The lack of somatic
hypermutation may reflect the need to avoid modification in
the periphery of the precise joint recognition of major
histocompatibility product plus antigen that is established
during thymic selection. The joint recognition process may
even require that germ line sequence be maintained in T-cell
receptor genes outside of the V-J junction region.
ACKNOWLEDGMENTS
This work was supported by a grant from the American Cancer
Society. David G. Schatz is a recipient of a fellowship from the Life
and Health Insurance Medical Research Fund.
M.R. was on leave from Biogen, Cambridge, Mass.
LITERATURE CITED
1. Alt, F., and D. Baltimore. 1982. Joining of immunoglobulin
heavy chain gene segments: implications from a chromosome
with evidence of three D-JH fusions. Proc. Natl. Acad. Sci.
USA 79:4118-4122.
2. Baltimore, D. 1974. Is terminal deoxynucleotidyl transferase a
somatic mutagen in lymphocytes? Nature (London) 248:409-
410.
3. Barth, R. K., B. S. Kim, N. C. Lan, T. Junkapilier, N. Sobiek, A.
Winoto, H. Gershenfeld, C. Okada, D. Hansburg, I. L. Weiss-
man, and L. Hood. 1985. The murine T-cell receptor uses a
limited repertoire of expressed Vp gene segments. Nature(London) 316:517-523.
4. Blackwell, T., and F. Alt. 1984. Site-specific recombination
between immunoglobulin D and JH segments that were intro-
duced into the genome of murine pre-B cell line. Cell 37:
105-112.
5. Bollum, F. J. 1974. Terminal deoxynucleotidyl transferase, p.
145. In P. D. Boyer (ed.), The enzymes, vol. 10. Academic
Press, Inc., New York.
6. Bollum, F. J., and M. Brown. 1979. A high molecular weight
form of terminal deoxynucleotidyl transferase. Nature (London)
278:191-192.
7. Cepko, C. L., B. E. Roberts, and R. C. Mulligan. 1984. Con-
struction and application of a highly transmissible murine ret-
rovirus shuttle vector. Cell 37:1053-1062.
8. Chang, L. M. S. 1971. Development of terminal deoxynu-
cleotidyl transferase activity in embryonic calf thymus gland.
Biochem. Biophys. Res. Commun. 44:124-128.
9. Chien, Y. H., N. R. J. Gascoigne, J. Kavaler, N. Lee, and M. M.
Davis. 1984. Somatic recombination in a murine T-cell receptor
gene. Nature (London) 309:322-326.
10. Coleman, M. S., J. J. Hutton, P. de Simone, and F. J. Bollum.
1974. Terminal deoxyribonucleotidyl transferase in human leu-
kemia. Proc. Natl. Acad. Sci. USA 71:4404-4408.
11. Desiderio, S., G. Yancopoulos, M. Paskind, E. Thomas, M. Boss,
N. Landau, F. Alt, and D. Baltimore. 1984. Insertion of N-
regions into heavy-chain genes is correlated with expression of
terminal deoxynucleotidyl transferase in B-cells. Nature (Lon-
don) 311:752-755.
12. Feinberg, A. P., and B. Vogelstein. 1983. A technique for
radiolabeling DNA restriction fragments to high specific activ-
ity. Anal. Biochem. 132:6-13.
13. Gearhart, P. J., N. D. Johnson, R. Douglas, and L. Hood. 1981.
IgG antibodies to phosphorylcholine exhibit more diversity than
their IgM counterparts. Nature (London) 291:29-34.
14. Graham, F. L., and A. J. van der Eb. 1973. A new technique for
the assay of infectivity of human adenovirus 5 DNA. Virology
52:456-467.
15. Kato, K., H. M. Goncalves, G. E. Gouts, and F. J. Bolium. 1967.
Deoxynucleotide-polymerizing enzymes of calf thymus gland. J.
Biol. Chem. 242:2780-2789.
16. Kim, S., M. Davis, E. Sinn, P. Patten, and L. Hood. 1981.
Antibody diversity: somatic hypermutation of rearranged VH
genes. Cell 27:573-581.
17. Koiwai, O., T. Yokota, T. Kageyama, T. Hirose, S. Yoshida, and
K. Arai. 1986. Isolation and characterization of bovine and
mouse terminal deoxynucleotidyltransferase cDNA's express-
ible in mammalian cells. Nucleic Acid Res. 14:5777-5781.
17a.Korman, A. J., J. D. Frantz, J. L. Strominger, and R. C.
Mulligan. 1987. Expression of human class II major histocom-
patibility complex antigens using retrovirus vectors. Proc. Natl.
MOL. CELL. BIOL.
N-REGION INSERTION IN TdT+ CELLS 3243
Acad. Sci. USA 84:2150-2154.
18. Kung, P. C., A. E. Silverstone, R. P. McCaffrey; and D.
Baltimore. 1976. Murine terminal deoxynucleotidyl transferase:
cellular distribution and response to cortisone. J. Exp. Med.
141:855-865.
19. Kurosawa, Y., and S. Tonegawa. 1982. Organization, structure,
and assembly of immunoglobulin heavy chain diversity DNA
segments. J. Exp. Med. 155:201-218.
20. Landau, N. R., T. P. St. John, I. L. Weissman, S. C. Wolf, A. E.
Silverstone, and D. Baltimore. 1984. Cloning of terminal trans-
ferase cDNA by antibody screening. Proc. Natl. Acad. Sci USA
81:5836-5840.
21. Lewis, S., A. Gifford, and D. Baltimore. 1984. Joining of VK to JK
gene segments in a retroviral vector introduced in lymphoid
cells. Nature (London) 308:425-428.
22. Lewis, S., A. Gifford, and D. Baltimore. 1985. DNA Elements
are asymmetrically joined during the site-specific recombination
of K immunoglobulin genes. Science 228:677485.
23. Lewis, S., N. Rosenberg, F. Alt, and D. Baltimore. 1982. Con-
tinuing K gene rearrangement in a cell line transformed by
Abelson murine leukemia virus. Cell 30:807-816.
24. Mann, R., R. Mulligan, anid D. Baltimore. 1983. Construction of
a retrovirus packaging mutant and its use to produce helper-free
defective retrovirus. Cell 33:153-159.
25. Max, E. E., J. V. Maizel, and P. Leder. 1981. The Nucleotide
sequence of a 5.5-kilobase DNA segment containing the mouse
K immunoglobulin J and C region genes. J. Biol. Chem.
256:5116-5120.
26. Maxam, A. M., and W. Gilbert. 1980. Sequencing end labeled
DNA with base-specific chemical cleavages. Methods Enzymol.
65:499-560.
27. McCaffrey, R., D. F. Smoler, and D. Baltimore. 1973. Terminal
deoxynucleotidyl transferase in a case of childhood acute
lymphoblastic leukemia. Proc. Natl. Acad. Sci. USA 70:36-40.
28. McCaffrey, R. P., T. A. Harrison, R. Parkman, and D. Balti-
more. 1975. Terminal deoxynucleotidyl transferase activity in
human leukemia cells and in normal human thymocytes. N.
Engl. J. Med. 292:775-780.
29. Nakamura, H., K. Tanabe, S. Toshida, and T. Morita. 1981.
Terminal deoxynucleotidyltransferase of 60,000 daltons from
mouse, rat, and calf thymus. J. Biol. Chem. 256:8745-8751.
30. Parker, B. A., and G. R. Stark. 1979. Regulation of simnian virus
40 transcription: sensitive analysis of the RNA species present
early in infections by virus or viral DNA. J. Virol. 31:360-369.
31. Peterson, R. C., L. C. Cheung, R. J. Mattaliano, L. M. S. Chang,
ahd F. J. Boilum. 1984. Molecular cloning of human terminal
deoxynucleotidyl transferase. Proc. Natl. Acad. Sci. USA 81:
4363-4367.
32. Peterson, R. C., L. C. Cheung, R. J. Mattaliano, S. T. White,
L. M. S. Chang, and F. J. Bollum. 1985. Expression of human
terminal deoxynucleotidyltransferase in Escherichia coli. J.
Biol. Chem. 260:10495-10502.
33. Roth, D. B., T. N. Porter, and J. H. Wilson. 1985. Mechanism of
nonhomologous recombination in mammalian cells. Mol. Cell.
Biol. 5:2599-2607.
34. Sakano, H., K. Huppi, G. Heinrich, and S. Tonegawa. 1979.
Sequences at the somatic recombination sites of immunoglobu-
lin light-chain genes. Nature (London) 280:288-294.
35. Silverstone, A. E., H. Cantor, G. Goldstein, and D. Baltimore.
1976. Terminal deoxynucleotidyl transferase is found in prothy-
mocytes. J. Exp. Med. 144:544-550.
36. Silverstone, A., L. Sun, 0. N. Witte, and D. Baltimore. 1980.
Biosynthesis of murine terminal deoxynucleotidyl transferase.
J. Biol. Chem. 255:791-795.
37. Southern, E. M. 1975. Detection of specific sequences among
DNA fragments separated by gel electrophoresis. J. Mol. Biol.
98:503-517.
38. Vogelstein, B., and D. Gillespie. 1979. Preparation and analytical
purification of DNA from agarose. Proc. Natl. Acad. Sci. USA
76:615419.
39. Yancopoulos, G. D., K. T. Blackwell, H. Suh, L. Hood, and
F. W. Alt. 1986. Introduced T cell receptor variable region gene
segments recombine in pre-B cells: evidence that B and T cells
use a common recombinase. Cell 44:251-259.
VOL. 7, 1987
